HealthDay on MSN
Early MS treatments impact relapses and brain scarring differently, but not disability
Key Takeaways B-cell-depleting therapy might help ward off MS relapses in early treatmentThis therapy also was associated ...
4hon MSN
Structurally guided therapy shows promise for patients with specific EGFR-mutated lung cancer
For patients with EGFR PACC-mutated non-small cell lung cancer (NSCLC), the targeted therapy firmonertinib achieved durable ...
The lobotomy procedure became a symbol of medical overreach in the 1960s. Brain surgery for mental illness still exists, but ...
A new Nature Neuroscience study shows that reactive ependymal cells with disrupted cell adhesion form a failing ventricular ...
A new review proposes that stress-induced overactivation of phospholipase A2 deposits toxic lysophospholipids directly at ...
Blood levels of the protein NfL may help predict the risk of future disease activity and progression in people with MS, a ...
The approach to testing for brain metastases differs between breast cancer and lung cancer.For lung cancer, a brain MRI is sometimes performed at the time of initial diagnosis, even in the absence of ...
Detected cases of a rare fungus that invades brain tissue and causes severe infections have risen roughly fourfold in the ...
The U.S. Food and Drug Administration (FDA) approved 13 drugs in September 2026, spanning first-in-class therapies, ...
A study shows how to reset the cells’ biological clock and turn back the clock whilst the cells specialise, but we are still ...
The 1st Criminal Division of the Busan High Court Ulsan Branch overturned the lower court's ruling that sentenced Mr.
HOUSTON, OCTOBER 16, 2026 ― For patients with EGFR PACC-mutated non-small cell lung cancer (NSCLC) , the targeted therapy firmonertinib achieved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results